SCHEMBL9954345

SCHEMBL9954345

Cc1ccc(-c2noc(C)c2C=O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.44
RAB9A P51151 4/20 0.42
MAPT P10636 3/20 0.42
NPSR1 Q6W5P4 3/20 0.42
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 5/20 0.42
GPBAR1 Q8TDU6 1/20 0.42
PKM P14618 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
NPC1 O15118 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
POLB P06746 1/20 0.41
HPGD P15428 1/20 0.41
PTK2B Q14289 1/20 0.41
PLK1 P53350 1/20 0.41
PTGS2 P35354 7/20 0.41
PTGS1 P23219 2/20 0.41
HTR1D P28221 1/20 0.41
HTR2A P28223 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL286321 0.86 PTGS2 (0.55) BRD4GPBAR1KMT2APLK1PTGS2
SCHEMBL195456 0.86 PTGS2 (0.58) BRD4MAPTNPSR1ALDH1A1PKM
SCHEMBL6096442 0.84 MAPK1 (0.43) BRD4RAB9AMAPTKDM4EALDH1A1
SCHEMBL9193604 0.80 PTGS2 (0.40) RAB9AMAPTNPSR1KDM4EALDH1A1
SCHEMBL9956465 0.80 GPBAR1 (0.46) BRD4RAB9AGPBAR1MEN1KMT2A
SCHEMBL10262365 0.75 PTGS2 (0.47) RAB9AMAPTNPSR1KDM4EALDH1A1
SCHEMBL21752799 0.74 GPBAR1 (0.48) BRD4ALDH1A1GPBAR1PLK1PTGS2
SCHEMBL18597726 0.71 POLB (0.51) BRD4RAB9AMAPTKDM4EALDH1A1
SCHEMBL8315811 0.71 TSHR (0.57) MAPTNPSR1KDM4EALDH1A1GPBAR1
SCHEMBL6093654 0.71 PTGS2 (0.53) BRD4MAPTNPSR1ALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012085857-A1 3,8-DIAZA-BICYCLO[4.2.0]OCT-3-YL AMIDES ACTELION PHARMACEUTICALS LTD (CH) 2012-06-28 WO disclosed